Accéder au contenu
Merck
  • NADf chip, a two-color microarray for simultaneous screening of multigene mutations associated with hearing impairment in North African Mediterranean countries.

NADf chip, a two-color microarray for simultaneous screening of multigene mutations associated with hearing impairment in North African Mediterranean countries.

The Journal of molecular diagnostics : JMD (2015-01-07)
Imen Chakchouk, Mariem Ben Said, Fida Jbeli, Riadh Benmarzoug, Salma Loukil, Ibtihel Smeti, Amine Chakroun, Abdullah Ahmed Gibriel, Abdelmonem Ghorbel, Hassen Hadjkacem, Saber Masmoudi
RÉSUMÉ

Hearing impairment (HI) is the most frequent sensory defect. Genetic causes are involved in two thirds of prelingual cases. Moreover, the autosomal recessive HI frequency is increased in countries where there is a high rate of consanguinity, such as in North African Mediterranean countries. This population shares several features, including history and social behavior, that promote the spread of founder mutations. HI is characterized by tremendous heterogeneity in both the genetic and clinical aspects. The identification of the causal mutation is important for early diagnosis, clinical follow-up, and genetic counseling. Addressing the extreme genetic heterogeneity of HI using classic molecular methods would be expensive and time-consuming. We designed a cost-effective North African Deafness chip for rapid and simultaneous analysis of 58 mutations using multiplex PCR coupled with dual-color arrayed primer extension. These mutations are found in North African HI patients and are distributed over 31 exons and five introns in 21 distinct genes. Assay specificity was initially optimized using 103 archived DNA samples of known genotypes. Blind validation of HI-unrelated patients revealed mutant alleles in 13 samples, and these mutations were confirmed by Sanger sequencing. The North African Deafness chip allows for simultaneous genotyping of eight different samples, at a minimal cost and in a single day, and is therefore amenable to large-scale molecular screening of HI in North Africa.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Hydriodic acid, 57 wt. % in H2O, distilled, stabilized, 99.95%
Sigma-Aldrich
Hydriodic acid, contains no stabilizer, ACS reagent, 55%
Sigma-Aldrich
Uracile, ≥99.0%
Sigma-Aldrich
Hydriodic acid, contains no stabilizer, distilled, 57 wt. % in H2O, 99.99% trace metals basis
Sigma-Aldrich
Hydriodic acid, contains ≤1.5% hypophosphorous acid as stabilizer, ACS reagent, ≥47.0%
Sigma-Aldrich
Uracile, BioReagent, suitable for cell culture
Sigma-Aldrich
Hydriodic acid, 57 wt. %, distilled, 99.999% trace metals basis
Supelco
Uracile, Pharmaceutical Secondary Standard; Certified Reference Material
Uracile, European Pharmacopoeia (EP) Reference Standard